A.P. Pharma, Inc. (APPA) Reports Third Quarter 2009 Financial Results
11/16/2009 10:14:16 AM
More...
|
A.P. Pharma, Inc. (APPA) to Transfer to Nasdaq Capital Market
10/28/2009 9:44:41 AM
More...
|
A.P. Pharma, Inc. (APPA) Announces Private Equity Placement
10/20/2009 6:58:36 AM
More...
|
A.P. Pharma, Inc. (APPA) Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
9/21/2009 9:40:15 AM
More...
|
A.P. Pharma, Inc. (APPA) and Merial Enter into Worldwide Agreement
9/15/2009 10:12:15 AM
More...
|
A.P. Pharma, Inc. (APPA) Reports Second Quarter 2009 Financial Results
8/4/2009 9:40:01 AM
More...
|
A.P. Pharma, Inc. (APPA) Receives Nasdaq Notice of Non-Compliance; Company to Request Hearing
7/20/2009 10:27:33 AM
More...
|
A.P. Pharma, Inc. (APPA) Announces FDA Acceptance of APF530 New Drug Application for Chemotherapy-Induced Nausea and Vomiting
7/20/2009 10:26:31 AM
More...
|
A.P. Pharma, Inc. (APPA) Receives Extension for Nasdaq Listing Compliance
6/3/2009 8:28:46 AM
More...
|
A.P. Pharma, Inc. (APPA) Presents APF530 Phase 3 Data at Annual Meeting of the American Society of Clinical Oncology
6/1/2009 8:38:26 AM
More...
|
|